- Diagnosis and therapy of multiple myeloma
-
Palumbo A, Cerrato C
- KMID: 1776445
- Korean J Intern Med.
- 2013 May;28(3):263-273.
- doi: 10.3904/kjim.2013.28.3.263
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel agents including thalidomide, lenalidomide, and bortezomib. The first... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation
-
Lee J, Kim BS, Park Y, Lee JG, Lim BJ, Jeong HJ, Kim YS, Huh KH
- KMID: 2345894
- Yonsei Med J.
- 2015 Nov;56(6):1638-1642.
- doi: 10.3349/ymj.2015.56.6.1638
PURPOSE: Recently, bortezomib has been used to treat antibody-mediated rejection (AMR) refractory to conventional treatment such as plasmapheresis, intravenous immunoglobulin, and rituximab. The authors aimed to describe their experiences when... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Free Light Chains for Diagnosis and Follow-up of Multiple Myeloma
-
Jung S, Kim M, Lim J, Kim Y, Han K, Min CK, Min WS
- KMID: 854861
- Korean J Lab Med.
- 2008 Jun;28(3):169-173.
- doi: 10.3343/kjlm.2008.28.3.169
BACKGROUND: Free light chain (FLC) is widely used to evaluate B-cell proliferative diseases. Herein, we estimated the clinical usefulness of serum FLC in multiple myeloma (MM). METHODS: Fifty-one patients were... -
- CITED
-
- Close
- SHARE
-
- Close
